Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
about
Optimization of radioimmunotherapy interactions with hyperthermia.Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.General overview of radioimmunotherapy of solid tumors.Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model.
P2860
Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@ast
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@en
type
label
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@ast
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@en
prefLabel
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@ast
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@en
P2093
P2860
P921
P1433
P1476
Phase I/II trial of combined 1 ...... ced colorectal adenocarcinoma.
@en
P2093
Benson AB 3rd
Mettler JM
Sathiaseelan V
P2860
P304
P356
10.1002/(SICI)1097-0142(19961101)78:9<1861::AID-CNCR4>3.0.CO;2-I
P407
P577
1996-11-01T00:00:00Z